BEDFORD, Mass.--(BUSINESS WIRE)--Anika Therapeutics, Inc. (NASDAQ:ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, announced today that it has signed an exclusive agreement with Artes Medical, Inc. (NASDAQ:ARTE), a medical aesthetics company, to distribute and market ELEVESS™, Anika’s cross-linked hyaluronic acid-based (HA) injectable dermal filler. ELEVESS is an injectable filler that reduces the appearance of facial wrinkles and folds such as nasolabial folds, and is the first HA-based dermal filler approved by the Food and Drug Administration (“FDA”) to incorporate the anesthetic lidocaine to improve patient comfort. Artes Medical manufactures, markets and sells ArteFill®, the first and only FDA-approved, nonresorbable dermal filler for the correction of smile lines.
